Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain

Autor: Octavio Rodriguez-Gomez, Laura Campo, Mercè Boada, Cristina Hernández, Angel Michael Ortiz Zuñiga, Rafael Simó, Laura Jamilis, Andreea Ciudin, Montserrat Alegret, Adrián Rodrigo

Publikováno v: Journal of Clinical Medicine
Volume 9
Issue 9
Journal of Clinical Medicine, Vol 9, Iss 2726, p 2726 (2020)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Introduction: Although the Diabetes Specific Dementia Risk Score (DSDRS) was proposed for predicting risk of dementia at 10 years, its usefulness as a screening tool is unknown. For this purpose, the European consortium MOPEAD included the DSDRS with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f27e04da286232af7ff29d40ccacda3
https://pubmed.ncbi.nlm.nih.gov/32847012